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Hematopoietic stem cells (HSCs) possess unique
gene expression programs that enforce their identity
and regulate lineage commitment. Long non-coding
RNAs (lncRNAs) have emerged as important re-
gulators of gene expression and cell fate decisions,
although their functions in HSCs are unclear. Here
we profiled the transcriptome of purified HSCs by
deep sequencing and identified 323 unannotated
lncRNAs. Comparing their expression in differ-
entiated lineages revealed 159 lncRNAs enriched
in HSCs, some of which are likely HSC specific
(LncHSCs). These lncRNA genes share epigenetic
features with protein-coding genes, including regu-
lated expression via DNA methylation, and knocking
down two LncHSCs revealed distinct effects on
HSC self-renewal and lineage commitment. Wemap-
ped the genomic binding sites of one of these candi-
dates and found enrichment for key hematopoietic
transcription factor binding sites, especially E2A.
Together, these results demonstrate that lncRNAs
play important roles in regulating HSCs, providing
an additional layer to the genetic circuitry controlling
HSC function.
INTRODUCTION
Hematopoietic stem cells (HSCs) continuously regenerate all
blood and immune cell types throughout life and are also capable
of self-renewal. Protein-coding genes specifically expressed in
HSCs (HSC ‘‘fingerprint’’ genes (Chambers et al., 2007) have
been identified by microarray studies, and many have been
shown to be functionally critical for HSC function (reviewed in
Rossi et al., 2012). Similarly, microRNAs can regulate HSC func-
tion (Lechman et al., 2012; O’Connell et al., 2008, 2010).
Recent whole transcriptome sequencing has revealed a large
number of putative long non-coding RNAs (lncRNAs). The func-
tion of some lncRNAs has been established in a limited scope of
biological processes, such as cell cycle regulation, embryonic426 Cell Stem Cell 16, 426–438, April 2, 2015 ª2015 Elsevier Inc.stem cell (ESC) pluripotency, lineage differentiation, and cancer
progression (Guttman et al., 2011; Hung et al., 2011; Klattenhoff
et al., 2013; Prensner et al., 2011). In the hematopoietic system,
only a few lncRNAs have been identified to be involved in differ-
entiation or quiescence. Xist-deficient HSCs exhibit aberrant
maturation and age-dependent loss (Yildirim et al., 2013), and
maternal deletion of the H19 regulatory elements reduced HSC
quiescence (Venkatraman et al., 2013). In addition, LncRNA
erythroid prosurvival (lincRNA-EPS) has been found to promote
terminal differentiation of mature erythrocytes by inhibiting
apoptosis (Hu et al., 2011), whereas HOTAIRM1 and eosinophil
granule ontogeny (EGO) are involved in granulocyte differentia-
tion (Wagner et al., 2007; Zhang et al., 2009). Furthermore, recent
genomic profiling identified thousands of lncRNAs expressed in
erythroid cells. Some of them have been shown to play a role in
erythroid maturation and erythro-megakaryocyte development
(Alvarez-Dominguez et al., 2014; Paralkar et al., 2014).
Nevertheless, lncRNAs function in HSCs still remains largely
unknown. Considering that lncRNAs usually exhibit cell type-
or stage-specific expression and HSCs are rare (0.01% of
bone marrow), we reasoned that many HSC-specific lncRNAs
may not have been identified and annotated yet. Notably, Cabe-
zas-Wallscheid et al. (2014) recently identified hundreds of
lncRNAs expressed in HSCs and compared their expression
with that in lineage-primed progenitors. However, without ex-
pression validation, comparison of expression in differentiated
lineages, and functional studies, their specificity and regulatory
role remains unclear. Therefore we aimed here to identify the
full complement of lncRNAs expressed in HSC with extremely
deep RNA sequencing to determine lncRNAs specific to HSCs
relative to representative differentiated lineages and also to
perform an initial analysis of their relevance to HSC function.
RESULTS
Identification of HSC-Specific lncRNAs
To identify unannotated putative lncRNAs, we purified the most
primitive long-term HSCs (SP-KSL-CD150+, hereafter termed
HSCs) from mouse bone marrow by fluorescence-activated
cell sorting (FACS). To uncover lncRNAs expressed in HSCs
across different ages, we performed RNA sequencing (RNA-
seq) on HSCs from 4-month-old (m04), 12-month-old (m12),
and 24-month-old (m24) mice (Sun et al., 2014), generating
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Figure 1. Identification of HSC-Specific LncRNAs
(A) Flowchart for the identification of LncHSCs. Filters indicate exclusion criteria.
(B) Heatmap to compare gene expression between HSCs, B cells (B), and granulocytes (Gr), including protein-coding genes, previously annotated lncRNAs, and
unannotated transcripts.
(C) Expression of the transcripts identified in HSCs, B cells, granulocytes, and 20 other tissues, including cerebellum, cortex, ESC, heart, kidney, lung, embryonic
fibroblasts (mouse embryonic fibroblasts [MEFs]), spleen, colon, duodenum,mammary gland, ovary, subcutaneous fat pad (subcutaneous adipose tissue [Sfat]),
genital fat pad (Gfat), stomach, testis, and thymus (GSE36025 and GSE36026).
(D) Coding potential prediction by CPAT for 503 unannotated transcripts identified in HSCs.
(E) UCSC browser track showing two LncHSCs with expression (green), H3K4me3 signal (pink), and H3K36me3 (blue).
(F) UCSC browser track showing one LncHSC is located in the UMR, with expression (green), H3K4me3 signal (pink) and DNA methylation (red), and UMR
(blue bar).
See also Figure S1 and Table S1.368, 311, and 293 million mapped reads for m04, m12, and m24
HSCs, respectively. To achieve the greatest power to detect un-
annotated transcripts, we also included RNA-seq data from
Dnmt3a knockout (KO) HSCs (Jeong et al., 2014) to reach a total
of 1,389 million mapped reads for the HSC transcriptome.
Although Dnmt3a KO HSCs differentiate inefficiently, they retain
many features of normal self-renewing HSCs, adding power to
novel gene discovery. In addition, we performed RNA-seq on
sorted bone marrow B cells (B220+) and granulocytes (Gr1+)
for comparison. We then performed a stringent series of filtering
steps to identify lncRNAs in different ages of wild-type (WT)
HSCs, including a minimum length of 200 bases and multiple
exons (Figure 1A).
We first verified the high quality of our data by confirming
the lineage-specific expression of known protein-coding ‘‘finger-print’’ genes (Chambers et al., 2007), such as Myct1, Ebf1, and
Cldn1, with HSC-, B cell-, and granulocyte-specific expression,
respectively (Figure S1A). Next, we identified 2,614 transcripts
annotated previously as non-coding RNAs by the University
of California, Santa Cruz (UCSC) Known Gene, RefSeq, or
Ensemble databases. Comparing their expressions in these
three cell types revealed that 154, 57, and 81 lncRNAs were en-
riched to HSCs, B cells, and granulocytes (Table S1), such as
AK018427, AK156636, and AK089406 (Figure S1B).
With known genes filtered out, we focused on the remaining
unannotated and multiply spliced transcripts, which resulted in
503 unannotated genes in HSCs. Comparison of the expression
of these transcripts in HSCs, B cells, and granulocytes revealed
that almost one-third were HSC-specific (Figure 1B). Comparing
their expression in 20 additional tissues (RNA-seq data fromCell Stem Cell 16, 426–438, April 2, 2015 ª2015 Elsevier Inc. 427
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Figure 2. Transcriptional Regulation of LncHSCs
(A) Heatmap depicting the expression of 159 LncHSCs: 4-month-old HSCs versus 12-month-old HSCs and 24-month-old HSCs (left) andWT versus Dnmt3a KO
HSCs (right).
(legend continued on next page)
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Encode) showed a generally low expression across most tis-
sues, except for a few expressed in testis (Figure 1C), suggesting
that they are highly hematopoietically enriched (HE) (Table S1).
Prediction of their coding probability using Coding Potential
Assessment Tool (CPAT) software (Wang et al., 2013) revealed
395 with a low coding probability (<0.44), representing likely
non-coding RNAs (Figure 1D). We further filtered out minimally
expressed transcripts in WT HSCs when their fragments per ki-
lobases of exons for per million mapped reads (FPKM) was <0.3
at all three different ages, which gave rise to 332 genes. Compar-
ison of their expressions in B cells and granulocytes resulted in
159 high-confidence lncRNAs that are HSC-enriched (Table
S1). A similar assembly of B cell and granulocyte RNA-seq reads
identified 124 B cell- (LncB) and 107 granulocyte-enriched
(LncGr), previously unannotated transcripts (Table S1). Notably,
most of the B cell-specific transcripts identified this way corre-
spond to antibody-variable regions.
We next examined the features of the set of HSC-enriched
lncRNAs (named LncHSCs). The LncHSCs generally have fewer
exons and lower expression but similar transcript lengths and
conservation (PhastCon) scores compared with protein-coding
genes (Figures S1C–S1F), in line with previous reports (Derrien
et al., 2012). Because retrovirus-related transposon elements
(TEs) have been shown to be enriched in ESC lncRNAs (Kelley
and Rinn, 2012), we considered whether this was also applicable
to LncHSCs. Consistent with a previous report (Kapusta et al.,
2013), we found that TEs cover about 40% of the genomic
sequence, 15% of known lncRNAs, but 5% of protein coding
genes. For LncHSCs, TEs (particularly LTR-associated; Fig-
ure S1G) contribute to about 35% of their genomic sequences.
These results suggest that LncHSCs here are distinct from pro-
tein-coding genes and likely to act as lncRNAs.
We further examined the chromatin state of the LncHSCs.
Chromatin immunoprecipitation sequencing (ChIP-seq) data
for two activation-associated histone marks, histone H3 Lys4 tri-
methylation (H3K4me3) and histone H3 Lys36 trimethylation
(H3K36me3), in purified WT HSCs were obtained from previous
studies (Sun et al., 2014; Jeong et al., 2014). For LncHSCs,
H3K4me3 was typically located at their predicted transcriptional
start site (TSS) and H3K36me3 along their gene bodies (Fig-
ure 1E). For DNA methylation, whole-genome DNA methylation
analysis in HSCs showed that 62% of lncHSCs are marked by
undermethylated regions (UMRs) in their promoter regions, and
some are even located in a methylation canyon (UMR >3.5 kb)
(Jeong et al., 2014). One example is located in a canyon with a
broad H3K4me3 peak (Figure 1F). Another example is a lncHSC
whose transcription originates from the promoter of an active
protein coding gene, but in the opposite direction (Figure S1H),(B) UCSC browser track showing the expression (green), H3K4me3 signal (pink), a
(3a KO) HSCs. Gray and black bars show differential DNA methylation between
(C) qRT-PCR analysis of selected LncHSCs. 50,000 KSL cells (c-Kit+Sca-1+Lin), C
granulocytes (Gr1+), and red blood cells (TER119+) were sorted for RT-PCR. The
mean ± SD).
(D) UCSC browser track showing DNA methylation (red), expression (green), H3K
(E) Representative images of LncHSC-1 expression in HSCs analyzed by RNA-FI
signal.
(F) Representative images of LncHSC-2 and LncGr-1 expression in HSCs and gra
red designates the LncGr-1 signal.
See also Figures S2 and S3.consistent with behavior previously noted as common among
lncRNAs (Sigova et al., 2013).LncHSCs Showed Altered Expression with HSC
Functional Decline
To gain insights into the function of LncHSCs in HSC self-
renewal and differentiation, we compared their expression be-
tween different HSC ages and between WT and Dnmt3a KO
HSCs because our previous studies showed that aged HSCs
exhibited a repopulation defect and myeloid-biased differentia-
tion, and Dnmt3a–/– HSCs exhibit defective differentiation and
enhanced self-renewal (Challen et al., 2012). There is a small
subset of LncHSCs (29 of 159) whose expression changes be-
tween 4- and 24-month-old HSCs (false discovery rate [FDR] <
1E-04). However, almost 58% of LncHSCs (92 of 159) showed
significant expression changes (FDR < 1E-04) between age-
matched m12 WT HSCs and Dnmt3a KO HSCs (Figure 2A). To
examine the basis for these differences at the epigenetic level,
whole-genome bisulfate sequencing of WT and Dnmt3a KO
HSCs (Jeong et al., 2014) was analyzed. Interestingly, a majority
of LncHSCs showed strong loss of DNA methylation at their
TSS regions after Dnmt3a KO, suggesting a role for Dnmt3a
in their regulation. For example, LncHSC-1 to LncHSC-6 all
show decreased methylation at their TSS regions. However,
decreased methylation was not always correlated with expres-
sion changes (Figure S2A). LncHSC-1 and LncHSC-2 exhibit
decreased expression, LncHSC-3 and LncHSC-4 show upregu-
lation and are accompanied by increased H3K4me3 (Figure 2B),
and LncHSC-5 and LncHSC-6 do not show significant expres-
sion changes (Figure S2B). This relatively poor correlation be-
tween DNAmethylation changes and gene expression alteration
resembles the observations from protein-coding genes (Challen
et al., 2012).
We also examined the promoters (TSS ± 5 kb) of LncHSCs for
critical HSC-associated transcription factor (TF) binding. Using
published ChIP-seq data for ten key HSC TFs, including Erg,
Fli1, Lmo2, Meis1, Gata2, Runx1, PU.1, Scl, Lyl1, and Gata2,
across a variety of blood lineages (more than ten) (Hannah
et al., 2011), we found that 51% of LncHSCs contain at least
one or more TF binding sites on their promoters (e.g., LncHSC-
1 and LncHSC-2; Figure S2C). Among these ten TFs, Erg, Flil1,
and Pu.1 are the top three factors, exhibiting binding sites near
38%, 29%, and 25% of LncHSCs, respectively. This percentage
is comparable with protein-coding genes but much higher than
the genome random control, suggesting that the expression of
LncHSCs may be precisely regulated by hematopoietic TFs
(Figure S2D).nd DNA methylation (red) for LncHSC-3 and LncHSC-4 in WT and Dnmt3a KO
WT and 3a KO HSCs.
D4 T cells (CD4+), CD8 T cells (CD8+), B cells (B220+), macrophages (Mac1+),
expression levels were plotted relative to that in KSL cells (set as 100, n = 3,
4me3 (pink), H3K27me3 (orange), H3K27ac (dark green), and H3K4me1 (blue).
SH. Green designates the 18S rRNA signal, and red designates the LncHSC-1
nulocytes analyzed by RNA-FISH. Green designates the LncHSC-2 signal, and
Cell Stem Cell 16, 426–438, April 2, 2015 ª2015 Elsevier Inc. 429
Next, we selected LncHSC-1 through LncHSC-6 for expres-
sion validation by quantitative RT-PCR. Among them, two over-
lapped with unannotated expressed sequence tags (ESTs):
LncHSC-1 (AK039852) and LncHSC-2 (DT926623). Notably,
LncHSC-2 is represented as an EST on Affymetrix microarrays
(MOE430 V2.0) and has been identified previously as an HSC
fingerprint gene (Chambers et al., 2007; Figure S2E). qRT-PCR
confirmed that LncHSC-1 through LncHSC-6 are highly ex-
pressed in stem and progenitor cell populations (c-Kit+Sca-
1+Lin [KSL]) but not, or at very low levels, in six other terminally
differentiated blood lineages (CD4, CD8, B220, Gr1, Mac1, and
Ter119; Figure 2C). For LncHSC-4, we detected a higher expres-
sion in erythroid cells (Ter119) than other blood lineages. Indeed,
LncHSC-4 (aka Lincred1; Tallack et al., 2012) has been shown
to be regulated by Klf1, Gata1, and Tal1 and, possibly, to be
involved in erythroid differentiation.
To gain insights into how LncHSCs control HSC function, we
focused on LncHSC-1 and LncHSC-2, which exhibit several
features of interest. These two transcripts are highly expressed
in WT HSC (FPKM > 3) but suppressed in Dnmt3a KO HSCs
(Figure S2B), and their promoter regions are bound by multiple
TFs in hematopoietic progenitor cells (Figure S2C). Further
expression analysis in HSC and different progenitors revealed
that LncHSC-1 is more HSC-specific, and LncHSC-2 is ex-
pressed in HSCs and also different progenitors but not termi-
nally differentiated cells (Figure S2F). Moreover, we found that
LncHSC-1 and LncHSC-2 are transcribed from enhancer re-
gions, marked by histone H3 Lys27 acetylation (H3K27ac) or his-
tone H3 Lys4 monomethylation (H3K4me1) but not H3K4me3
and H3K27me3 (Figure 2D). LncHSC-1 is located close to
two functionally important coding genes, Zfp36l2 and Thada.
Genomic translocation has been reported within Thada and
distal to the Zfp36l2 locus in various myeloid malignancies
(Trubia et al., 2006). In addition, heterozygous mutations of
Zfp36l2 have been detected in leukemias (Iwanaga et al.,
2011). Zfp36l2 homozygous knockout mice die from HSC failure
within 2 weeks of birth (Stumpo et al., 2009), and, recently, it has
been reported that Zfp36l2 is required for self-renewal of
erythroid progenitors (Zhang et al., 2013). The human synteny
block, including LncHSC-1, is also located close to THADA
and ZFP36L2 on chromosome 2. RNA-seq data from bone
marrow of The Cancer Genome Atlas (TCGA) patients (Ley
et al., 2010) indicated that there are several unannotated tran-
scripts expressed in this region. However, based on sequence
homology, we could not identify specific orthologs to LncHSC-
1, consistent with generally poor conservation for lncRNAs
across species (Ulitsky et al., 2011). In mouse HSCs, there
are four LncHSCs (LncHSC-1, LncHSC-3, LncHSC-82, and
LncHSC-13) close to the Thada and Zfp36l2 genes, all four of
which showed expression changes after Dnmt3a KO, with
LncHSC-1 and LncHSC-13 downregulated and LncHSC-3
and LncHSC-82 upregulated (Figure S3A). To examine how
the transcripts in this region were impacted by human DNMT3A
mutations, we reconstructed and selected, from TCGA
acute myeloid leukemia (AML) patient data, one abundantly
expressed transcript at this region (corresponding to the EST
tag AF150238; Figure S3B), and found that patients with a
DNMT3A mutation showed increased expression (p value =
0.01; Figure S3C). These data suggest a similar regulation430 Cell Stem Cell 16, 426–438, April 2, 2015 ª2015 Elsevier Inc.of putative lncRNAs by DNA methylation in this syntenic region
despite the lack of clear sequence homology. For lncHSC-2, it
is close to a protein-coding gene, Pkn2, and sequence compar-
ison by nucleotide-nucleotide BLAST (BLASTN) revealed that
it is highly homologous (87.6%) to a 3-kb region in its human
synteny block, which is also close to the PKN2 gene. However,
we did not detect expressed transcripts at this region in TCGA
patients.
LncRNA function is also dependent on subcellular localization.
Enhancer-associated lncRNAs aremore enriched in the nucleus,
whereas lncRNAs involved in other functions such as posttran-
scriptional and translational processes tend to be more cyto-
plasmic. We therefore performed RNA fluorescence in situ
hybridization (FISH) to determine the localization of LncHSCs.
LncHSC-1 is mainly located in the HSC nucleus compared
with the control 18S rRNA (Figure 2E). In parallel, LncHSC-2 is
also located in the HSC nucleus, suggesting that LncHSC-1
and LncHSC-2 are likely functional noncoding RNAs. To confirm
their specificity, we also examined one granulocyte-enriched
LncRNA (LncGr-1), which was found to be exclusively expressed
in granulocytes but not in HSCs (Figure 2F).
LncHSCsControl HSC In Vitro and In Vivo Differentiation
To characterize the functions of LncHSC-1/2, we generated ret-
rovirally expressed constructs to knock down their expression
(Figure 3A). In stem and progenitor cells (Sca-1+), the knock-
down (KD) constructs led to 50%–70% reduction of their expres-
sion by RT-PCR (Figure 3B). To examine their effects on HSC
self-renewal and differentiation, retrovirally transduced KSL-
GFP+ cells were sorted after 2 days of in vitro culture and plated
in methylcellulose for colony-forming unit (CFU) assays. Knock-
down of those transcripts had no effect on colony number or line-
age specificity after the first plating (Figure S3D). However, after
the second plating, KD of LncHSC-1 significantly increased the
colony numbers compared with the control, suggesting that
progenitors with reduced LncHSC-1 in the first plating had not
undergone terminal differentiation (Figure 3C). Indeed, KD of
LncHSC-1 led to an increase in cells expressing the HSC/pro-
genitor marker c-Kit (Figure S3D), and cells from second-plating
colonies had a more homogeneous morphology (Figure 3D).
Next we performed transplantation to examine the function
of LncHSC1/2 in vivo. Because we observed that KD of
LncHSC-1 increased the myeloid colony number in vitro, we
also generated retroviral constructs to overexpress LncHSC-1
in stem/progenitor cells. However, after transplantation for
16 weeks, even though the LncHSC-1 transcript level increased
almost 500-fold in the GFP+ (Linc-kit+ Sca-1+) KSL cell popula-
tion, there was no difference in lineage differentiation (Figures
S3E and S3F). Meanwhile, we transplanted stem/progenitor
cells transduced with the LncHSC-1/2 KD constructs. 16 weeks
after transplantation, the percentages of donor-derived cells
(CD45.2+) in the peripheral blood (PB) were similar between the
groups. However, although the initial transduction efficiency
(Figure S4A) and donor engraftment efficiency (Figure S4B) are
similar, the percentage of the GFP+ population varied signifi-
cantly between different groups (Figure 4A), possibly because
of the effects of LncHSC onHSC self-renewal. To determine their
impact on lineage differentiation, we compared the percentage
of different lineages within the GFP+ population. We found that
Figure 3. LncHSCs Regulate HSC Differentiation In Vitro
(A) Flow chart depicting knockdown of LncHSC for in vitro and in vivo functional studies. 5-FU, 5-fluorouracil.
(B) Quantitative RT-PCR showing LncHSCs knockdown. Sca-1+ cells were transduced with knockdown constructs and cultured in vitro for 2 days, and then
20,000 GFP+ cells were sorted for RT-PCR (n = 3, mean ± SD).
(C) Methylcellulose CFU assay using 200 KSL-GFP+ cells (transduced by LncHSC-1 KD-1 and LncHSC-2 KD-1). Sorted cells were put into one well of 6-well plate
containing Methocult3434, and the average colony numbers were counted after 14 days. For the second plating, 2,000 live cells from the colonies obtained in the
first plating were plated as before and cultured for 14 days. **p < 0.01. (n = 3, mean ± SD). Data are representative of three experiments.
(D) Morphology of cells from the colonies at the second plating by cytospin.
See also Figure S3.KDof LncHSC-1 significantly increasedmyeloid differentiation at
the expense of B cells compared with control KD, in alignment
with the in vitro findings. In contrast, KD of LncHSC-2 signifi-
cantly increased T cell lineage and decreased B cell output.
As a control, the CD45.2+GFP– population showed similar
lineage distributions between different groups (Figure 4B). To
confirm the KD efficiency in vivo, we isolated bone marrow
(BM) GFP+KSL cells 20 weeks after transplantation for RT-PCR
and confirmed that LncHSCs were knocked down (Figure S4C).We further performed lineage, progenitor, andHSCanalyses in
the bonemarrowafter 20weeks. Notably, thebonemarrowGFP+
population in the LncHSC-1 KD-1 and LncHSC-2 KD-2 groups
was too low for detailed HSC and progenitor analyses, so we
focused on the LncHSC-1 KD-2 (short hairpin RNA [shRNA] #2)
and LncHSC-2 KD-1 (shRNA#1) groups. We found that there
were no significant differences for the granulocyte-macrophage
progenitor (GMP), common myeloid progenitor (CMP), and
megakaryocyte-erythroid progenitor (MEP) population or theCell Stem Cell 16, 426–438, April 2, 2015 ª2015 Elsevier Inc. 431
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Figure 4. LncHSCs Control HSC Function In Vivo
(A) Contribution of retrovirally transduced donor HSCs (CD45.2+GFP+) to recipient mouse PB after primary transplantation. *p < 0.05, **p < 0.01. Error bars
represent mean ± SEM (n = 10 for control KD and 5–8 for LncHSCs KD).
(B) Analysis of HSC differentiation in peripheral blood at 16 weeks post-primary transplant. The percentage of the indicated lineages within CD45.2+GFP
or CD45.2+GFP+ cell compartments are shown. Myeloid cells (Mye) were defined as Gr1+ and Mac1+, B cells (B) are B220+, and T cells (T) are CD4+ and CD8+.
**p < 0.01, ***p < 0.001. Error bars represent mean ± SEM (n = 10 for control KD and 5–8 for LncHSCs KD).
(C) Contribution of donor HSCs (CD45.2+GFP or CD45.2+GFP+) to recipient mouse PB after secondary transplantation. Data are mean ± SEM (n = 5-6). For
secondary transplantation, 500 CD45.2+GFP+ KSL cells from primary recipients were re-sorted 20weeks after transplantation, mixedwith 250,000 CD45.1WBM
cells, and injected into new lethally irradiated CD45.1 recipients.
(legend continued on next page)
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long-term (LT)-HSC, short-termHSC, andmultipotent progenitor
populations after KD (Figure S4D). However, we observed that
KD of LncHSC-1 led to increased myeloid cells and lineage-
negative c-kit-positive (LK) cells (myeloid progenitors) and that
KD of LncHSC-2 led to more T cells, consistent with the periph-
eral analysis (Figure S4E).
To examine HSC self-renewal activity, 500 BM GFP+KSL cells
from primary recipients of LncHSC-1 (KD-2) and LncHSC-2
(KD-1) were sorted and transplanted into secondary recipients.
Peripheral blood (PB) analysis showed that GFP+ levels
were comparable between different groups (Figure 4C). KD
of LncHSC-1 increased myeloid differentiation, and KD of
LncHSC-2 increased T cell differentiation, consistent with pri-
mary transplantation results (Figure 4D). For the bone marrow
analysis 16 weeks after secondary transplantation, interestingly,
the percentage of the side population (SP) and KSL cells was
decreased for LncHSC-2 KD, suggesting that LncHSC-2 is
involved in HSC long-term self-renewal (Figure 4E).
Although the bone marrow of primary recipients of LncHSC-2
KD-2-transduced cells had too few GFP+ cells for a detailed
analysis, we were able to isolate enough KSL GFP+ cells from
a pool of these mice to perform secondary transplantation to
verify the effect on self-renewal. Again, we observed that the per-
centage of GFP+ cells in the peripheral blood was very low at
4 weeks and almost undetectable at 16 weeks (Figure S4F).
This precluded us from performing a lineage analysis with this
KD construct. In the bone marrow at 16 weeks, we observed
dramatically decreased total GFP+ cells for both LncHSC-2 KD
constructs but not LncHSC-1 KD (Figure S4G). These results
suggest that both shRNAs for LncHSC-2 affected HSC self-
renewal but with different efficiency.
The mechanisms through which lncRNAs work are largely
obscure and likely to vary. It has been shown that lncRNAs can
modulate gene expression through RNA-protein, RNA-RNA, or
RNA-DNA interactions (Guttman and Rinn, 2012). To determine
the immediate impact on gene expression after LncHSC KD,
stem and progenitor cells were transduced with a retrovirus.
After in vitro culture for 2 days, GFP+ KSL cells were purified
and subjected to RNA-seq. As expected, the results revealed
the targeted LncHSCs were specifically reduced. However,
we only identified 70 and 84 significantly changed genes
after KD of LncHSC-1 and LncHSC-2, respectively (Table S2).
Moreover, we did not see any expression changes of neigh-
boring genes after KD of either LncHSC-1 or LncHSC-2, indi-
cating that LncHSC-1 and LncHSC-2 are possibly trans-acting
lncRNAs.
ChIRP-Seq Reveals LncHSC-2 Occupancy Sites
Genome-wide
To better understand the functions of LncHSCs, we sought to
determine their binding sites by chromatin isolation by RNA pu-
rification sequencing (ChIRP-seq) (Chu et al., 2011; Engreitz(D) Analysis of peripheral blood cells 16 weeks post-secondary transplant. The pe
compartments are shown. Myeloid cells were defined as Gr1+ and Mac1+, B cells
represent mean ± SEM (n = 5–6).
(E) Bonemarrow FACS analysis showing frequencies of side population, LK, and L
mean ± SEM. **p < 0.01 (n = 3–6).
See also Figure S4 and Table S2.et al., 2013; Simon et al., 2011). Given the technical challenges
because of the limited number of primary HSCs, we utilized
HPC5 cells, a mouse bone marrow-derived multipotent progen-
itor line (Pinto do O et al., 2002) that expresses LncHSC-2
at levels comparable with primary HSCs. We therefore per-
formed ChIRP-seq to identify LncHSC-2 binding sites using
HPC5 cells. After pull-down, RT-PCR showed that more than
90% of LncHSC-2 RNA was pulled down. For the negative con-
trol, less than 1% of GAPDH RNA was pulled down (Figure S5A).
From CHIRP-seq, we identified 264 LncHSC-2 binding sites
concordant in three of four biological replicates and absent in
a LacZ negative control (for peak coordinates, see Table S3).
Similar to transcription factors, LncHSC-2 binding sites were
focal (median size, 284 base pairs [bp]), and most did not spread
beyond 600 bp. The distribution of binding sites showed that
11% were localized to promoter/50 UTR elements (Figure 5A,
left), representing a 3- to 7-fold enrichment over the genome
background (Figure 5A, right). The remaining peaks occurred pri-
marily in intronic and intergenic regions.
Next we asked whether LncHSC-2 accesses the genome
through specific DNA sequences. A motif analysis of LncHSC-2
binding sites identified four core motifs (Table S4), suggesting
that specific DNA motifs may be involved in LncHSC-2 occu-
pancy. To further characterize the motifs, we quantified their sim-
ilarity toknownDNAsequencemotifs. This revealedasignificantly
enriched bHLHmotif corresponding to a transcription factor E2A
isoformencodedbyTcf3 (Figure5B;TableS4).E2Aproteinsact to
promote the developmental progression of the entire spectrum of
early hematopoietic progenitors, including LT-HSC, MPP, and
common lymphoid progenitors (Semerad et al., 2009). To gain in-
sights into potential LncHSC-2-mediated chromatin states, we
tested the overrepresentation of its occupied sites (relative to
the LacZ control) among the ChIP-seq profiles of hematopoietic
transcriptional regulators and epigenetic marks in LT-HSC,multi-
potent progenitors (HPC-7cells), aswell as tissues (bonemarrow,
thymus, and spleen). LncHSC-2 sites were characterized by sig-
nificant enrichment of undermethylated CpG regions (UMRs), the
active histone marks H3K4me3/H3K27ac, and the TFs Erg/Fli1/
Meis1/Pu.1 (Figure 5C; Table S5). Remarkably, a Genomic Re-
gions Enrichment of Annotations Tool (GREAT) analysis of mouse
genotype-phenotype associations showed that gene and pro-
moter proximal binding sites were significantly enriched almost
exclusively for hematopoietic and immune system phenotypes
(14 of 16 terms with binomial test, q < 0.05), including abnormal
lymphopoiesis (Table S5).
Having identified potential associations between LncHSC-2
and individual transcriptional regulators and epigenetic marks,
we next analyzed occupancy patterns of regions bound by
LncHSC-2 and enriched factors by hierarchical clustering. This
analysis separated LncHSC-2-bound sites into two major clus-
ters: undermethylated promoter proximal regions associated
with activating chromatin marks (H3K4me3 and H3K27ac) andrcentage of the indicated lineages within CD45.2+GFP– and CD45.2+GFP+ cell
are B220+, and T cells are CD4+ and CD8+. **p < 0.01, ***p < 0.001. Error bars
SK cells 16weeks after secondary transplantation in mice. Error bars represent
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hematopoietic TFs and promoter-distal intergenic/intronic re-
gions associated with insulator CTCF, enhancers, or E2A binding
motifs (Figure 5D). One LncHSC-2-occupied site containing an
E2A motif mapped to the intronic region of the Pml (promyelo-
cytic leukemia protein) gene locus (Figure 5E). As a tumor
suppressor, Pml is essential for HSC maintenance, and its
deficiency affects all hematopoietic lineages in recipient mice
after BM transplant (Ito et al., 2008). The core promoter of Itpkb
is a site of potential co-occupancy by LncHSC-2 and the TFs
Erg, Pu.1, Fli1, and Meis1 (Figure 5E). Mice lacking Itpkb, the B
isoform of the Ins(1,4,5)P3 3-kinase, have a complete and
specific T cell deficiency because of a developmental block at
the double-positive thymocyte stage (Pouillon et al., 2003). Other
LncHSC-2 co-occupied promoter regions include Cox5b, Itgb2,
Tnf, and Slc35c2 (Figure S5B).
Because a motif analysis showed that lncHSC-2 binding
sites are highly enriched for E2A binding, we wondered
whether LncHSC-2 is involved in recruiting E2A to its target
sites. To address this question, we analyzed previous ChIP-
seq data for E2A binding in HPC7 cells and found that there
are almost 20 binding peaks overlapped between E2A and
LncHSC-2 (Table S5). From them, we selected three sites
with the highest scores of enrichment, which are close to the
genes Nln, Slc35c2, and Itgb2, respectively. Interestingly,
ChIP qPCR showed that E2A binding on these sites was abro-
gated after LncHSC-2 KD (Figure 5F), suggesting that
LncHSC-2 is directly involved or responsible for E2A binding
on some target sites.
Recent studies have implicated transposable elements such
as endogenous retroviruses (ERVs) and long terminal repeats
(LTRs) in the evolution, regulation, and function of lncRNAs
(Kapusta et al., 2013; Kelley and Rinn, 2012). To measure
whether LncHSC-2 was enriched at any classes of repetitive
elements, we performed peak calling again with both unique
and multiple-mapped paired-end reads (including up to two
alignments). The results show that LncHSC-2 binding sites
are specifically enriched for the ERVL-mammalian apparent
LTR retrotransposon LTR families of repeats and depleted of
long interspersed nuclear elements (L1), short interspersed nu-Figure 5. ChIRP-Seq Reveals LncHSC-2 Binding Sites in the Genome
(A) LncHSC-2 binding sites are enriched in promoter-proximal regions. Left: th
intragenic regions. Right: enrichment of LncHSC-2 sites (versus the genomic ba
(B) Enriched sequence motif associated with lncHSC-2 binding sites (bottom) st
(C) Co-enrichment analysis of lncHSC-2 binding sites with sequence features, ChI
in HSCs, multipotent progenitors (HPC-7 cells), bone marrow, thymus, and sple
control was assessed by Fisher’s exact test with multiple testing correction. Co
feature (green), and TF binding site (blue). Dot sizes are proportionate to the odd
value.
(D) Hierarchical clustering of genomic regions bound by lncHSC-2 and published
separates LncHSC-2 occupancy into two main branches, with unmethylated
(H3K4me3/H3K27ac/PolII) and Erg/Fli/Meis1/Pu.1 TFs to the left and promoter dis
or insulator elements (CTCF) E2A sequence motifs to the right. Each line corresp
absence of the additional given factors.
(E) LncHSC-2 occupancy at the genes Pml (top) and Itpkb (bottom). Shown are
MACS2 representing the fragment pileup signal per million reads. Additional overla
2014), and hematopoietic lineage TF binding sites (Wilson et al., 2010).
(F) ChIP qPCR to show E2A binding to three LncHSC-2 binding peaks after Ln
immunoprecipitated DNA compared with the input. Mean ± SEM values are sho
See also Figure S5 and Tables S3, S4, S5, and S6.clear elements (B4 and Alu), and Simple repeats (Figure S5C;
Table S6).
DISCUSSION
In this study, we carried out a comprehensive RNA-seq analysis
in purified HSCs, differentiated B cells, and granulocytes. We
discovered 2,614 known lncRNAs and almost 500 unannotated
transcripts expressed in HSCs. This list contains almost all of
the lncRNAs identified from in a previous study (Cabezas-Wall-
scheid et al., 2014) but is more comprehensive. Furthermore,
we performed a series of analyses to characterize those
lncRNAs, including examining their conservation, overlap with
repeats, and correlation with DNA methylation and histone
marks.
Although the known lncRNAs may play important functions
for HSCs, in this study we specifically focused on previously
unannotated transcripts and identified 159 high-confidence
LncHSCs compared with the representative differentiated line-
ages of B cells and granulocytes. Among them, we demon-
strated that LncHSC-1 and LncHSC-2 are located in the nucleus
and expressed differentially betweenWT and Dnmt3a KOHSCs.
KD of LncHSC1/2 revealed that LncHSC-1 is involved in myeloid
differentiation and that LncHSC-2 is involved in HSC self-
renewal and T cell differentiation. Moreover, we determined
that LncHSC-2 bind sites are enriched for the hematopoietic-
specific TF binding sites, especially E2A, which is a well-recog-
nized regulator of hematopoietic differentiation.
How Complete Is Our Catalog of Potential HSC-Specific
LncRNAs?
Herewe used extremely deep sequencing data (> 1.3 billion HSC
reads when combined) to detect lncRNA expression in HSCs.
The number of transcripts that are truly unique to HSCs could
be reduced when similarly deep sequencing was performed
across additional hematopoietic lineages and when lncRNAs
shared with progenitors were eliminated. On the other hand,
our filtering criteria were highly stringent, including size, splicing,
and expression level criteria, and we excluded putative lncRNAse distribution of LncHSC-2 binding sites across the indicated intergenic or
ckground) among transcript features. CDS, coding sequence.
rongly resembling the mouse Tcfe2a secondary motif (top).
P-seq profiles of hematopoietic transcriptional regulators and epigenetic marks
en. The enrichment for LncHSC-2 binding compared with the LacZ negative
lors subdivide the results into three classes: epigenetic mark (red), sequence
s ratio. The x axis values represent the –log Benjamini-Hochberg-corrected p
hematopoietic lineage TFs or epigenetic marks. The major partition of columns
promoter-proximal regions associated with transcriptional activation marks
tal intronic or intergenic regions associated with bone marrow tissue enhancer
onds to a LncHSC-2 peak, where blue/white coloring indicates the presence/
LncHSC-2 and LacZ control ChIRP-seq signal density tracks generated by
id tracks are HSCH3K4me3, RNA-seq, undermethylated regions (Jeong et al.,
cHSC-2 KD in primary Sca-1+ cells. The y axis represents the percentage of
wn (n = 4).
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that overlapped with protein-coding genes and their extended
30 UTRs, even when they were predicted by splice motif analysis
to be transcribed in the opposite direction of the associated
coding gene. In this regard, all lncRNAs identified in our study
are intergenic, which may underestimate the number of bona
fide HSC-specific lncRNAs. Finally, our use of poly-A+ RNA
and filtering criteria likely excludes many enhancer RNAs
(eRNAs) (Natoli and Andrau, 2012), another interesting set of
non-coding RNAs. Therefore, with this comprehensive but con-
servative approach, we can expect that these 159 LncHSCs,
because of their low expression in most other tissues (Figure 1),
are unlikely to have been discovered using any other approach.
This relatively small number (a total of 300 HSC-specific
lncRNAs including those annotated previously) is aligned with
the small number of protein-coding genes (300) thought to be
uniquely expressed in HSCs comparedwith other blood lineages
(Chambers et al., 2007) and is larger than the number of B cell- or
granulocyte-specific lncRNAs, perhaps suggesting their partic-
ular roles in primitive cells.
Functional Characterization of LncHSCs
More data on the functional relevance of lncRNAs will be needed
to understand their importance relative to protein-coding genes.
About two-thirds (116 of 152) of reported protein-coding gene
KOs result in some degree of hematopoietic defect after HSC
or bone marrow transplantation (Rossi et al., 2012). Here both
LncHSCs we tested in vivo showed an impact on lineage differ-
entiation, and LncHSC-2 showed an effect on self-renewal after
KD and transplantation. Although the shRNAs we used here pro-
vide an efficient strategy for initial screening, further confirmation
of these phenotypes using complete ablation and rescue exper-
iments would be of value in the future.
In addition to functional studies, mapping the binding sites of
LncHSC-2 using ChIRP-seq revealed that they are enriched for
TF binding sites. KD of LncHSC-2 blocked E2A binding on
some target sites, suggesting that LncHSC-2 is involved in TF
binding. Whether LncHSC-2 binds directly to TFs or through
other complexes to recruit them would need to be further
examined.
Although lncRNAs are recognized as being less conserved
across species than coding genes, we identified a human syn-
tenic region with several putative lncRNAs that changed in
DNMT3A mutant AML patients in concordance with changes
in similarly localized transcripts in mouse Dnmt3a KO HSCs.
Whether these LncHSCs contribute to disease development re-
mains to be determined, but the frequent mutation ofDNMT3A in
AML (Ley et al., 2010; Yan et al., 2011) and other hematologic
malignancies (Goodell and Godley, 2013), and the observation
that >50% of LncHSCs change in expression after Dnmt3a KO,
suggest that this relationship warrants further investigation.
EXPERIMENTAL PROCEDURES
See Supplemental Information for more extensive methods.
HSC Purification
All animal procedures were IUCAC-approved and conducted in accordance
with institutional guidelines. Whole bone marrow cells were isolated from
mouse femurs, tibiae, pelves, and humeri. LT-HSCs were purified using the
SP method, as described previously (Goodell et al., 1996), in conjunction436 Cell Stem Cell 16, 426–438, April 2, 2015 ª2015 Elsevier Inc.with the following cell surface markers: Lineage– (CD3, CD4, CD8, B220,
Gr1, Mac1, and T119) and Sca-1+ c-Kit+ CD150+.
RNA Sequencing
RNA was isolated from FACS-sorted HSCs with the RNeasy micro kit
(QIAGEN). Paired-end libraries were generated with the Illumina TruSeq RNA
kit. Alignment was performed by RNA-seq unified mapper (Grant et al.,
2011). Cufflinks and Cuffdiff (Trapnell et al., 2010) were used for transcript
reconstruction, quantification, and differential expression analysis.
shRNA Cloning and Viral Transduction
Oligos targeting each desired transcript were cloned with the BLOCK-iT PolII
miRRNAi expression vector kit (Invitrogen). The oligoswere further recombined
into the retroviral MSCV-RFB vector. For retroviral transduction of hematopoi-
etic progenitors, the suspension was spin-infected at 2503 g at room temper-
ature for 2 hr in the presence of polybrene (4 mg/ml). For in vivo transplantation,
cells were incubated for a further 1 hr at 37C. For in vitro assays, transduced
cells were cultured in fresh transduction medium for a further 2 days.
In Vivo Transplantation
C57Bl/6 CD45.1 mice were transplanted by retro-orbital injection following a
split dose of 10.5 Gy of lethal irradiation. 50,000 Sca-1+ (CD45.2) donor cells
were injected into the recipient mice. For secondary transplantation, 500
CD45.2+GFP+ KSL cells from primary recipients were re-sorted 20weeks after
transplantation, mixed with 250,000 CD45.1 whole bone marrow (WBM) cells,
and injected into new lethally irradiated recipients.
FISH
Single-molecule RNA FISH was performed using the QuantiGene ViewRNA
ISH cell assay according to the manufacturer’s instructions (Affymetrix). Im-
ages were taken on an API Deltavision deconvolution microscope (Applied
Precision).
ChIRP
ChIRP was performed as described previously (Chu et al., 2011).
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